Replies to post #12899 on Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

Regarding the 15:1 reverse split in mid-2010, in mid-2008 the FDA issued a not approvable letter for Vitaros. Short of cash the company sold the Vitaros US rights for a cheap song. By mid-2010 the company would have been delisted on the nasdaq unless it could get its pps up. Thus the reverse split. Approval of Vitaros by Health Canada didn't occur until November 2010.